Which hedge funds own GPCR? STRUCTURE THERAPEUTICS INC, Q2 2026 13F holders
59 tracked hedge funds disclosed a position in GPCR (STRUCTURE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $1.3bn in total. The largest holder by portfolio weight is NEXTBio Capital Management LP at 7.7% of its book. 9 opened a new position this quarter: RTW Investments, LP, Fox Run Management, L.L.C., EntryPoint Capital, LLC, Fulcrum Asset Management LLP. 13 exited: Sio Capital Management, LLC, Diadema Partners LP, Paradigm Biocapital Advisors LP.
- 59
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 9
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 13
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $98.5m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $85.1m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.3bn
- Combined value Sum of the holders' reported positions in the security.
- 4.8%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Sio Capital Management, LLC | 1.5% | $10.1m |
| Diadema Partners LP | 1.4% | $3.5m |
| Paradigm Biocapital Advisors LP | 0.5% | $26.3m |
| Persistent Asset Partners Ltd | 0.3% | $880k |
| Scientech Research LLC | 0.3% | $335k |
| Pentwater Capital Management LP | 0.08% | $11.8m |
| Trexquant Investment LP | 0.04% | $5.2m |
| Balyasny Asset Management L.P. | 0.03% | $14.7m |
| Aquatic Capital Management LLC | 0.02% | $714k |
| Holocene Advisors, LP | 0.02% | $7.7m |
| Walleye Capital LLC | 0.01% | $1.0m |
| Renaissance Technologies LLC | 0.0% | $2.7m |
| Jain Global LLC | 0.0% | $278k |
Ownership over time
Who discovered GPCR first? Beta
The run: Q1 2025 → Q4 2025, +302%
| Deep Track Capital, LP high conviction | Q2 2024 | 2.3% | +5.9 pts |
| Casdin Capital, LLC high conviction | Q2 2025 | 1.0% | +4.7 pts |
| Rock Springs Capital Management LP | Q2 2024 | 1.1% | +1.6 pts |
| Ikarian Capital, LLC | Q3 2024 | 1.5% | +0.2 pts |
| First Light Asset Management, LLC | Q2 2024 | 0.3% | −0.7 pts |
| Wexford Capital LP | Q3 2024 | 0.1% | −0.7 pts |
| Vestal Point Capital, LP | Q2 2024 | 2.2% | −1.9 pts |
| Exome Asset Management LLC | Q3 2024 | 1.6% | −2.2 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.